Sovan Sarkar

Sovan Sarkar

Auto-generated profile, based on publicly available information

Sovan Sarkar

Institute of Cancer and Genomic Sciences, Institute of Biomedical Research, College of Medical and Dental Sciences, University of Birmingham

Research Focus & Metrics

Academic Career Length

24Years (2003-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2010 in Physiological Reviews
Verified
Journal Article
Closed access
PDF file
BRBrinda Ravikumar
Brinda Ravikumar
SSSovan Sarkar
Sovan Sarkar
JDJanet E. Davies
Janet E. Davies
MFMarie Futter
Marie Futter
MGMoises Garcia-Arencibia
Moises Garcia-Arencibia
DRDavid C. Rubinsztein
David C. Rubinsztein
(Macro)autophagy is a bulk degradation process that mediates the clearance of long-lived proteins and organelles. Autophagy is initiated by double-membraned structures, which engulf portions of cytoplasm. The resulting autophagosomes ultimately fuse with lysosomes, where their contents are degraded. Although the term autophagy was first used in 1963, the field has witnessed dramatic growth in the last 5 years, partly as a consequence of the discovery of key components of its cellular machinery. In this review we focus on mammalian autophagy, and we give an overview of the understanding of its machinery and the signaling cascades that regulate it. As recent studies have also shown that autophagy is critical in a range of normal human physiological processes, and defective autophagy is associated with diverse diseases, including neurodegeneration, lysosomal storage diseases, cancers, and Crohn's disease, we discuss the roles of autophagy in health and disease, while trying to critically evaluate if the coincidence between autophagy and these conditions is causal or an epiphenomenon. Finally, we consider the possibility of autophagy upregulation as a therapeutic approach for various conditions.

1 February 2007 in Journal of Biological Chemistry
Verified
Journal Article
Open access
PDF file
SSSovan Sarkar
Sovan Sarkar
JDJanet E. Davies
Janet E. Davies
ZHZebo Huang
Zebo Huang
ATAlan Tunnacliffe
Alan Tunnacliffe
David C RubinszteinDavid C Rubinsztein
David C Rubinsztein
Trehalose, a disaccharide present in many non-mammalian species, protects cells against various environmental stresses. Whereas some of the protective effects may be explained by its chemical chaperone properties, its actions are largely unknown. Here we report a novel function of trehalose as an mTOR-independent autophagy activator. Trehalose-induced autophagy enhanced the clearance of autophagy substrates like mutant huntingtin and the A30P and A53T mutants of α-synuclein, associated with Huntington disease (HD) and Parkinson disease (PD), respectively. Furthermore, trehalose and mTOR inhibition by rapamycin together exerted an additive effect on the clearance of these aggregate-prone proteins because of increased autophagic activity. By inducing autophagy, we showed that trehalose also protects cells against subsequent pro-apoptotic insults via the mitochondrial pathway. The dual protective properties of trehalose (as an inducer of autophagy and chemical chaperone) and the combinatorial strategy with rapamycin may be relevant to the treatment of HD and related diseases, where the mutant proteins are autophagy substrates.

23 June 2013 in Nature Biotechnology
Verified
Journal Article
Open access
PDF file
GSGaurav Sahay
Gaurav Sahay
WQWilliam Querbes
William Querbes
CAChristopher Alabi
Christopher Alabi
AEAhmed Eltoukhy
Ahmed Eltoukhy
SSSovan Sarkar
Sovan Sarkar
DADaniel G Anderson
Daniel G Anderson
Detailed analyses of siRNA delivery by lipid nanoparticles reveal major pathways of siRNA internalization and endosomal escape. Despite efforts to understand the interactions between nanoparticles and cells, the cellular processes that determine the efficiency of intracellular drug delivery remain unclear. Here we examine cellular uptake of short interfering RNA (siRNA) delivered in lipid nanoparticles (LNPs) using cellular trafficking probes in combination with automated high-throughput confocal microscopy. We also employed defined perturbations of cellular pathways paired with systems biology approaches to uncover protein-protein and protein–small molecule interactions. We show that multiple cell signaling effectors are required for initial cellular entry of LNPs through macropinocytosis, including proton pumps, mTOR and cathepsins. siRNA delivery is substantially reduced as ≅70% of the internalized siRNA undergoes exocytosis through egress of LNPs from late endosomes/lysosomes. Niemann-Pick type C1 (NPC1) is shown to be an important regulator of the major recycling pathways of LNP-delivered siRNAs. NPC1-deficient cells show enhanced cellular retention of LNPs inside late endosomes and lysosomes, and increased gene silencing of the target gene. Our data suggest that siRNA delivery efficiency might be improved by designing delivery vehicles that can escape the recycling pathways.

13 March 2011 in Nature Cell Biology
Verified
Journal Article
Open access
PDF file
VKViktor Korolchuk
Viktor Korolchuk
SSShinji Saiki
Shinji Saiki
MLMaike Lichtenberg
Maike Lichtenberg
FSFarah H. Siddiqi
Farah H. Siddiqi
EREsteban A. Roberts
Esteban A. Roberts
David C RubinszteinDavid C Rubinsztein
David C Rubinsztein
The subcellular position of lysosomes, whether adjacent to the plasma membrane or perinuclear, regulates mTOR signalling and autophagy in response to nutrient availablity. Lysosomal position is regulated by changes in intracellular pH. mTOR (mammalian target of rapamycin) signalling and macroautophagy (henceforth autophagy) regulate numerous pathological and physiological processes, including cellular responses to altered nutrient levels. However, the mechanisms regulating mTOR and autophagy remain incompletely understood. Lysosomes are dynamic intracellular organelles1,2 intimately involved both in the activation of mTOR complex 1 (mTORC1) signalling and in degrading autophagic substrates3,4,5,6,7,8. Here we report that lysosomal positioning coordinates anabolic and catabolic responses with changes in nutrient availability by orchestrating early plasma-membrane signalling events, mTORC1 signalling and autophagy. Activation of mTORC1 by nutrients correlates with its presence on peripheral lysosomes that are physically close to the upstream signalling modules, whereas starvation causes perinuclear clustering of lysosomes, driven by changes in intracellular pH. Lysosomal positioning regulates mTORC1 signalling, which in turn influences autophagosome formation. Lysosome positioning also influences autophagosome–lysosome fusion rates, and thus controls autophagic flux by acting at both the initiation and termination stages of the process. Our findings provide a physiological role for the dynamic state of lysosomal positioning in cells as a coordinator of mTORC1 signalling with autophagic flux.

26 September 2005 in Journal of Cell Biology
Verified
Journal Article
Open access
PDF file
SSSovan Sarkar
Sovan Sarkar
RFR. Andres Floto
R. Andres Floto
ZBZdenek Berger
Zdenek Berger
SISara Imarisio
Sara Imarisio
ACAxelle Cordenier
Axelle Cordenier
DRDavid C. Rubinsztein
David C. Rubinsztein
Macroautophagy is a key pathway for the clearance of aggregate-prone cytosolic proteins. Currently, the only suitable pharmacologic strategy for up-regulating autophagy in mammalian cells is to use rapamycin, which inhibits the mammalian target of rapamycin (mTOR), a negative regulator of autophagy. Here we describe a novel mTOR-independent pathway that regulates autophagy. We show that lithium induces autophagy, and thereby, enhances the clearance of autophagy substrates, like mutant huntingtin and α-synucleins. This effect is not mediated by glycogen synthase kinase 3β inhibition. The autophagy-enhancing properties of lithium were mediated by inhibition of inositol monophosphatase and led to free inositol depletion. This, in turn, decreased myo-inositol-1,4,5-triphosphate (IP3) levels. Our data suggest that the autophagy effect is mediated at the level of (or downstream of) lowered IP3, because it was abrogated by pharmacologic treatments that increased IP3. This novel pharmacologic strategy for autophagy induction is independent of mTOR, and may help treatment of neurodegenerative diseases, like Huntington's disease, where the toxic protein is an autophagy substrate.

23 March 2008 in Nature Chemical Biology
Verified
Journal Article
Open access
PDF file
AWAndrea Williams
Andrea Williams
SSSovan Sarkar
Sovan Sarkar
PCPaul Cuddon
Paul Cuddon
ETEvangelia K Ttofi
Evangelia K Ttofi
SSShinji Saiki
Shinji Saiki
DRDavid C Rubinsztein
David C Rubinsztein
Autophagy is a major clearance route for intracellular aggregate-prone proteins causing diseases such as Huntington's disease. Autophagy induction with the mTOR inhibitor rapamycin accelerates clearance of these toxic substrates. As rapamycin has nontrivial side effects, we screened FDA-approved drugs to identify new autophagy-inducing pathways. We found that L-type Ca2+ channel antagonists, the K+ATP channel opener minoxidil, and the Gi signaling activator clonidine induce autophagy. These drugs revealed a cyclical mTOR-independent pathway regulating autophagy, in which cAMP regulates IP3 levels, influencing calpain activity, which completes the cycle by cleaving and activating Gsα, which regulates cAMP levels. This pathway has numerous potential points where autophagy can be induced, and we provide proof of principle for therapeutic relevance in Huntington's disease using mammalian cell, fly and zebrafish models. Our data also suggest that insults that elevate intracytosolic Ca2+ (like excitotoxicity) inhibit autophagy, thus retarding clearance of aggregate-prone proteins.